Results 151 to 160 of about 17,138 (226)

The SGLT2 Inhibitor Dapagliflozin Disrupts the Cell Cycle at High Concentrations Without Altering Glycosphingolipid (De Novo)Biosynthesis. [PDF]

Int J Mol Sci
Jennemann R, Sandhoff R.
europepmc   +1 more source

Pioneering microbial synthesis of gangliosides in the filamentous fungus Ashbya gossypii. [PDF]

Biotechnol Biofuels Bioprod
Montero-Bullón JF, Martín-González J, Ledesma-Amaro R, Jiménez A, Buey RM.   +4 more
europepmc   +1 more source

Sphingolipids and Mortality in Hemodialysis: Innocent Bystanders or Causal Culprits? [PDF]

J Am Soc Nephrol
Saum KL, Pennathur S.
europepmc   +1 more source

Rethinking Metabolic Dysfunction in Chronic Liver Diseases. [PDF]

touchREV Endocrinol
Mak LL.
europepmc   +1 more source

Multi-omic analysis reveals lipid dysregulation associated with mitochondrial dysfunction in parkinson's disease brain. [PDF]

Nat Commun
Hällqvist J, Toomey CE, Pinto R, Baldwin T, Doykov I, Wernick A, Al Shahrani M, Evans JR, Lachica J, Pope S, Heales S, Eaton S, Mills K, Gandhi S, Heywood WE.   +14 more
europepmc   +1 more source

Bioactive Glycosphingolipids

Journal of Japan Oil Chemists' Society, 1991
openaire   +2 more sources

Ganglioside therapy in cancer molecular insights and therapeutic opportunities. [PDF]

Discov Oncol
Banerjee A, Banerjee S, Maity SR, Das A.
europepmc   +1 more source

How should kidney injury in Fabry disease be assessed and monitored? [PDF]

Kidney Res Clin Pract
Song SH.
europepmc   +1 more source

Phosphorylated glycosphingolipids are commonly detected in Caenorhabditis elegans lipidomes. [PDF]

Metabolomics
Witting M, Salzer L, Meyer SW, Barsch A.
europepmc   +1 more source